(-)-epigallocatechin 3-gallate decreases expression EXP 6480464 epigallocatechin gallate results in decreased expression of PARK7 mRNA CTD PMID:25585349 (1->4)-beta-D-glucan multiple interactions EXP 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of PARK7 mRNA CTD PMID:36331819 (R,R,R)-alpha-tocopherol multiple interactions ISO RGD:1344212 6480464 alpha-Tocopherol inhibits the reaction [Rotenone affects the localization of PARK7 protein] CTD PMID:16439141 (S)-nicotine multiple interactions EXP 6480464 [Nicotine co-treated with 1-Methyl-4-phenyl-1 more ... CTD PMID:20230807 1,2-dimethylhydrazine multiple interactions EXP 6480464 [1, 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of PARK7 mRNA CTD PMID:22206623 1-bromopropane decreases expression ISO RGD:621808 6480464 1-bromopropane results in decreased expression of PARK7 protein CTD PMID:21925529 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine decreases response to substance EXP 6480464 PARK7 protein results in decreased susceptibility to 1-Methyl-4-phenyl-1 more ... CTD PMID:15784737 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine multiple interactions EXP 6480464 [Nicotine co-treated with 1-Methyl-4-phenyl-1 more ... CTD PMID:20230807 , PMID:22511790 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine increases expression EXP 6480464 1-Methyl-4-phenyl-1 more ... CTD PMID:20230807 15-deoxy-Delta(12,14)-prostaglandin J2 multiple interactions ISO RGD:621808 6480464 15-deoxy-delta(12 more ... CTD PMID:22245093 17beta-hydroxy-17-methylestra-4,9,11-trien-3-one increases expression ISO RGD:1344212 6480464 Metribolone results in increased expression of PARK7 protein CTD PMID:17152098 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of PARK7 mRNA CTD PMID:21570461 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:621808 6480464 Tetrachlorodibenzodioxin results in decreased expression of PARK7 mRNA CTD PMID:32109520 , PMID:34747641 2-amino-14,16-dimethyloctadecan-3-ol decreases expression ISO RGD:1344212 6480464 2-amino-14, 16-dimethyloctadecan-3-ol results in decreased expression of PARK7 protein CTD PMID:32044396 3-chloropropane-1,2-diol increases expression ISO RGD:621808 6480464 alpha-Chlorohydrin analog results in increased expression of PARK7 protein, alpha-Chlorohydrin results in increased expression of PARK7 protein CTD PMID:26072098 , PMID:26597043 3-chloropropane-1,2-diol increases oxidation EXP 6480464 alpha-Chlorohydrin results in increased oxidation of PARK7 protein CTD PMID:31712104 3-chloropropane-1,2-diol affects expression ISO RGD:621808 6480464 alpha-Chlorohydrin affects the expression of PARK7 protein CTD PMID:26072098 4,4'-sulfonyldiphenol increases expression ISO RGD:1344212 6480464 bis(4-hydroxyphenyl)sulfone results in increased expression of PARK7 protein CTD PMID:34186270 4-phenylbutyric acid increases expression ISO RGD:621808 6480464 4-phenylbutyric acid results in increased expression of PARK7 protein CTD PMID:21372141 4-phenylbutyric acid multiple interactions ISO RGD:1344212 6480464 4-phenylbutyric acid inhibits the reaction [Rotenone results in increased expression of PARK7 protein] CTD PMID:17459145 4-phenylbutyric acid multiple interactions EXP 6480464 4-phenylbutyric acid inhibits the reaction [Rotenone results in increased expression of PARK7 protein] CTD PMID:17459145 4-phenylbutyric acid increases expression ISO RGD:1344212 6480464 4-phenylbutyric acid results in increased expression of PARK7 mRNA, 4-phenylbutyric acid results in increased expression of PARK7 protein CTD PMID:21372141 4-phenylbutyric acid increases expression EXP 6480464 4-phenylbutyric acid results in increased expression of PARK7 protein CTD PMID:21372141 4-phenylbutyric acid multiple interactions ISO RGD:621808 6480464 [4-phenylbutyric acid results in increased expression of PARK7 protein] which results in decreased susceptibility to Hydrogen Peroxide, [4-phenylbutyric acid results in increased expression of PARK7 protein] which results in decreased susceptibility to Oxidopamine CTD PMID:21372141 6-propyl-2-thiouracil decreases expression ISO RGD:621808 6480464 Propylthiouracil results in decreased expression of PARK7 mRNA CTD PMID:24780913 amiodarone increases expression EXP 6480464 Amiodarone results in increased expression of PARK7 mRNA CTD PMID:24489787 ammonium chloride affects expression ISO RGD:621808 6480464 Ammonium Chloride affects the expression of PARK7 mRNA CTD PMID:16483693 amphetamine affects response to substance EXP 6480464 PARK7 protein affects the susceptibility to Amphetamine CTD PMID:15784737 arsenite(3-) multiple interactions ISO RGD:1344212 6480464 arsenite promotes the reaction [G3BP1 protein binds to PARK7 mRNA] CTD PMID:32406909 astemizole increases expression ISO RGD:621808 6480464 Astemizole results in increased expression of PARK7 mRNA CTD PMID:20221588 benomyl decreases activity ISO RGD:1344212 6480464 Benomyl results in decreased activity of PARK7 protein CTD PMID:36842454 benzene decreases expression ISO RGD:1344212 6480464 Benzene results in decreased expression of PARK7 mRNA CTD PMID:16188089 benzo[a]pyrene affects methylation ISO RGD:1344212 6480464 Benzo(a)pyrene affects the methylation of PARK7 5' UTR CTD PMID:27901495 benzo[a]pyrene decreases expression ISO RGD:1344212 6480464 Benzo(a)pyrene results in decreased expression of PARK7 mRNA CTD PMID:34332006 bisphenol A affects localization EXP 6480464 bisphenol A affects the localization of PARK7 protein CTD PMID:23037695 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of PARK7 mRNA CTD PMID:35598803 bisphenol A increases methylation ISO RGD:1344212 6480464 bisphenol A results in increased methylation of PARK7 gene CTD PMID:31601247 bisphenol A increases expression ISO RGD:1344212 6480464 bisphenol A results in increased expression of PARK7 protein CTD PMID:33670352 bisphenol A decreases expression ISO RGD:621808 6480464 bisphenol A results in decreased expression of PARK7 mRNA CTD PMID:33296240 bisphenol A affects expression ISO RGD:1344212 6480464 bisphenol A affects the expression of PARK7 mRNA CTD PMID:30903817 bisphenol A multiple interactions ISO RGD:1344212 6480464 bisphenol A promotes the reaction [PARK7 protein binds to ESR1 protein] CTD PMID:27156127 bisphenol A increases expression ISO RGD:621808 6480464 bisphenol A results in increased expression of PARK7 mRNA CTD PMID:25181051 bromobenzene affects binding ISO RGD:621808 6480464 bromobenzene metabolite binds to PARK7 protein CTD PMID:17305373 butyric acid increases expression ISO RGD:1344212 6480464 Butyric Acid results in increased expression of PARK7 mRNA, Butyric Acid results in increased expression of PARK7 protein CTD PMID:21372141 butyric acid increases expression ISO RGD:621808 6480464 Butyric Acid results in increased expression of PARK7 protein CTD PMID:21372141 butyric acid increases expression EXP 6480464 Butyric Acid results in increased expression of PARK7 protein CTD PMID:21372141 cadmium atom multiple interactions ISO RGD:1344212 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of PARK7 mRNA CTD PMID:35301059 cadmium dichloride decreases expression ISO RGD:1344212 6480464 Cadmium Chloride results in decreased expression of PARK7 protein CTD PMID:24419708 cadmium dichloride multiple interactions ISO RGD:1344212 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of PARK7 mRNA CTD PMID:35301059 cannabidiol multiple interactions ISO RGD:1344212 6480464 [Cuprizone co-treated with Cannabidiol] results in decreased expression of PARK7 protein CTD PMID:34122009 captan decreases activity ISO RGD:1344212 6480464 Captan results in decreased activity of PARK7 protein CTD PMID:36842454 CCCP multiple interactions EXP 6480464 PARK7 gene mutant form promotes the reaction [Carbonyl Cyanide m-Chlorophenyl Hydrazone affects the localization of PRKN protein] CTD PMID:22872702 CGP 52608 multiple interactions ISO RGD:1344212 6480464 CGP 52608 promotes the reaction [RORA protein binds to PARK7 gene] CTD PMID:28238834 chlorpyrifos increases expression EXP 6480464 Chlorpyrifos results in increased expression of PARK7 mRNA CTD PMID:29156651 chlorpyrifos decreases expression EXP 6480464 Chlorpyrifos results in decreased expression of PARK7 mRNA CTD PMID:37019170 chromium trinitrate increases expression EXP 6480464 chromium nitrate results in increased expression of PARK7 protein CTD PMID:22144121 chromium(6+) affects expression EXP 6480464 chromium hexavalent ion affects the expression of PARK7 mRNA CTD PMID:28472532 cisplatin multiple interactions EXP 6480464 [Cisplatin co-treated with Lutein] results in decreased expression of PARK7 mRNA CTD PMID:24865317 cisplatin decreases expression ISO RGD:1344212 6480464 Cisplatin results in decreased expression of PARK7 protein CTD PMID:25450742 cisplatin decreases expression EXP 6480464 Cisplatin results in decreased expression of PARK7 mRNA CTD PMID:21151649 , PMID:24865317 clozapine increases expression EXP 6480464 Clozapine results in increased expression of PARK7 mRNA CTD PMID:14647396 cobalt dichloride decreases expression ISO RGD:1344212 6480464 cobaltous chloride results in decreased expression of PARK7 mRNA CTD PMID:19376846 copper atom affects binding ISO RGD:1344212 6480464 Copper binds to PARK7 protein CTD PMID:23792957 copper(0) affects binding ISO RGD:1344212 6480464 Copper binds to PARK7 protein CTD PMID:23792957 crocidolite asbestos affects expression ISO RGD:1344212 6480464 Asbestos, Crocidolite affects the expression of PARK7 mRNA CTD PMID:17331233 Cuprizon increases expression ISO RGD:621808 6480464 Cuprizone results in increased expression of PARK7 mRNA CTD PMID:27523638 Cuprizon multiple interactions ISO RGD:1344212 6480464 [Cuprizone co-treated with Cannabidiol] results in decreased expression of PARK7 protein CTD PMID:34122009 DDE decreases activity ISO RGD:1344212 6480464 Dichlorodiphenyl Dichloroethylene results in decreased activity of PARK7 protein CTD PMID:36842454 dexamethasone decreases expression EXP 6480464 Dexamethasone results in decreased expression of PARK7 protein CTD PMID:33567340 diazinon decreases expression ISO RGD:621808 6480464 Diazinon results in decreased expression of PARK7 mRNA CTD PMID:21968025 diazinon decreases activity ISO RGD:1344212 6480464 Diazinon results in decreased activity of PARK7 protein CTD PMID:36842454 dibenziodolium multiple interactions EXP 6480464 diphenyleneiodonium inhibits the reaction [Lipopolysaccharides results in increased expression of PARK7 protein] CTD PMID:11811539 dibutyl phthalate decreases expression EXP 6480464 Dibutyl Phthalate results in decreased expression of PARK7 mRNA CTD PMID:21266533 dicrotophos decreases expression ISO RGD:1344212 6480464 dicrotophos results in decreased expression of PARK7 mRNA CTD PMID:28302478 Dienochlor decreases activity ISO RGD:1344212 6480464 dienochlor results in decreased activity of PARK7 protein CTD PMID:36842454 disodium selenite increases expression ISO RGD:1344212 6480464 Sodium Selenite results in increased expression of PARK7 mRNA CTD PMID:18175754 dithianon multiple interactions ISO RGD:1344212 6480464 dithianone results in decreased activity of and results in increased oxidation of PARK7 protein CTD PMID:36842454 diuron decreases expression ISO RGD:1344212 6480464 Diuron results in decreased expression of PARK7 mRNA CTD PMID:35967413 doxorubicin decreases response to substance ISO RGD:1344212 6480464 PARK7 protein results in decreased susceptibility to Doxorubicin CTD PMID:24675091 enzyme inhibitor multiple interactions ISO RGD:1344212 6480464 [Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of PARK7 protein CTD PMID:23301498 fenazaquin increases response to substance EXP 6480464 PARK7 mutant form results in increased susceptibility to fenazaquin CTD PMID:21219333 fenpyroximate decreases response to substance EXP 6480464 PARK7 protein results in decreased susceptibility to fenpyroximate CTD PMID:21219333 flavonoids decreases expression ISO RGD:621808 6480464 Flavonoids results in decreased expression of PARK7 mRNA CTD PMID:18035473 folic acid multiple interactions EXP 6480464 [1, 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of PARK7 mRNA CTD PMID:22206623 folpet decreases activity ISO RGD:1344212 6480464 folpet results in decreased activity of PARK7 protein CTD PMID:36842454 formetanate decreases activity ISO RGD:1344212 6480464 formetanate results in decreased activity of PARK7 protein CTD PMID:36842454 gamma-hexachlorocyclohexane decreases activity ISO RGD:1344212 6480464 Hexachlorocyclohexane results in decreased activity of PARK7 protein CTD PMID:36842454 Garcinol multiple interactions ISO RGD:1344212 6480464 garcinol inhibits the reaction [1-Methyl-4-phenylpyridinium results in decreased expression of PARK7 protein] CTD PMID:36629037 glutathione increases abundance ISO RGD:1344212 6480464 PARK7 protein results in increased abundance of Glutathione CTD PMID:18331584 glyphosate increases expression EXP 6480464 glyphosate results in increased expression of PARK7 protein CTD PMID:36173347 haloperidol increases expression EXP 6480464 Haloperidol results in increased expression of PARK7 mRNA CTD PMID:14647396 heparin increases expression ISO RGD:621808 6480464 Heparin results in increased expression of PARK7 protein CTD PMID:17488504 hydralazine multiple interactions ISO RGD:1344212 6480464 [Hydralazine co-treated with Valproic Acid] results in increased expression of PARK7 mRNA CTD PMID:17183730 hydrogen peroxide increases expression ISO RGD:1344212 6480464 Hydrogen Peroxide results in increased expression of PARK7 protein CTD PMID:11811539 hydrogen peroxide affects metabolic processing EXP 6480464 PARK7 protein affects the metabolism of Hydrogen Peroxide CTD PMID:24936441 hydrogen peroxide multiple interactions EXP 6480464 PRKN gene mutant form inhibits the reaction [Hydrogen Peroxide affects the localization of PARK7 protein] CTD PMID:22872702 hydrogen peroxide affects localization EXP 6480464 Hydrogen Peroxide affects the localization of PARK7 protein CTD PMID:22872702 hydrogen peroxide multiple interactions ISO RGD:621808 6480464 [4-phenylbutyric acid results in increased expression of PARK7 protein] which results in decreased susceptibility to Hydrogen Peroxide CTD PMID:21372141 hydrogen peroxide decreases response to substance ISO RGD:1344212 6480464 PARK7 protein results in decreased susceptibility to Hydrogen Peroxide CTD PMID:18377993 inulin multiple interactions EXP 6480464 [perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of PARK7 mRNA CTD PMID:36331819 isoniazide affects expression EXP 6480464 Isoniazid affects the expression of PARK7 mRNA CTD PMID:24848797 ivermectin decreases expression ISO RGD:1344212 6480464 Ivermectin results in decreased expression of PARK7 protein CTD PMID:32959892 lactacystin decreases response to substance ISO RGD:1344212 6480464 PARK7 protein results in decreased susceptibility to lactacystin CTD PMID:18331584 lipopolysaccharide multiple interactions EXP 6480464 diphenyleneiodonium inhibits the reaction [Lipopolysaccharides results in increased expression of PARK7 protein] more ... CTD PMID:11811539 , PMID:26691871 lipopolysaccharide increases expression EXP 6480464 Lipopolysaccharides results in increased expression of PARK7 protein CTD PMID:11811539 lipopolysaccharide affects localization EXP 6480464 Lipopolysaccharides affects the localization of PARK7 protein CTD PMID:19063952 lutein multiple interactions EXP 6480464 [Cisplatin co-treated with Lutein] results in decreased expression of PARK7 mRNA CTD PMID:24865317 LY294002 multiple interactions ISO RGD:621808 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [manganese chloride results in decreased expression of PARK7 protein] CTD PMID:22245093 mancozeb multiple interactions ISO RGD:1344212 6480464 mancozeb results in decreased activity of and results in increased oxidation of PARK7 protein CTD PMID:36842454 maneb decreases activity ISO RGD:1344212 6480464 Maneb results in decreased activity of PARK7 protein CTD PMID:36842454 maneb multiple interactions ISO RGD:1344212 6480464 3-(4-(morpholin-4-yl)-7H-pyrrolo(2 more ... CTD PMID:34897981 , PMID:36842454 manganese atom decreases expression ISO RGD:621808 6480464 Manganese results in decreased expression of PARK7 protein CTD PMID:20798247 manganese(0) decreases expression ISO RGD:621808 6480464 Manganese results in decreased expression of PARK7 protein CTD PMID:20798247 manganese(II) chloride multiple interactions ISO RGD:621808 6480464 15-deoxy-delta(12 more ... CTD PMID:22245093 manganese(II) chloride decreases expression ISO RGD:621808 6480464 manganese chloride results in decreased expression of PARK7 mRNA, manganese chloride results in decreased expression of PARK7 protein CTD PMID:20798247 , PMID:22245093 meloxicam multiple interactions ISO RGD:1344212 6480464 meloxicam inhibits the reaction [Paraquat promotes the reaction [Quinones binds to PARK7 protein]] CTD PMID:20851755 mercury atom increases expression ISO RGD:1344212 6480464 Mercury results in increased expression of PARK7 mRNA CTD PMID:16823088 mercury atom affects binding ISO RGD:1344212 6480464 Mercury binds to PARK7 protein CTD PMID:23792957 mercury(0) increases expression ISO RGD:1344212 6480464 Mercury results in increased expression of PARK7 mRNA CTD PMID:16823088 mercury(0) affects binding ISO RGD:1344212 6480464 Mercury binds to PARK7 protein CTD PMID:23792957 N,N-diethyl-m-toluamide multiple interactions ISO RGD:621808 6480464 [Pyridostigmine Bromide co-treated with DEET co-treated with Permethrin] results in increased expression of PARK7 mRNA CTD PMID:28659758 N-acetyl-L-cysteine multiple interactions ISO RGD:1344212 6480464 Acetylcysteine inhibits the reaction [3-(2-hydroxy-4-(1 more ... CTD PMID:18377993 more ... N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal multiple interactions ISO RGD:621808 6480464 PARK7 protein affects the reaction [benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in increased expression of HSPA1A protein] CTD PMID:18331584 N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal multiple interactions ISO RGD:1344212 6480464 benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [Paraquat results in increased sulfation of and results in increased oxidation of PARK7 protein] CTD PMID:26409479 N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal decreases response to substance ISO RGD:1344212 6480464 PARK7 protein results in decreased susceptibility to benzyloxycarbonylleucyl-leucyl-leucine aldehyde CTD PMID:18331584 N-methyl-4-phenylpyridinium increases expression EXP 6480464 1-Methyl-4-phenylpyridinium results in increased expression of PARK7 mRNA CTD PMID:26558463 N-methyl-4-phenylpyridinium multiple interactions ISO RGD:1344212 6480464 garcinol inhibits the reaction [1-Methyl-4-phenylpyridinium results in decreased expression of PARK7 protein] CTD PMID:36629037 N-methyl-4-phenylpyridinium decreases expression ISO RGD:1344212 6480464 1-Methyl-4-phenylpyridinium results in decreased expression of PARK7 protein CTD PMID:36629037 N-nitrosomorpholine decreases expression ISO RGD:621808 6480464 N-nitrosomorpholine results in decreased expression of PARK7 protein CTD PMID:19716841 nicotine multiple interactions EXP 6480464 [Nicotine co-treated with 1-Methyl-4-phenyl-1 more ... CTD PMID:20230807 ouabain affects response to substance EXP 6480464 PARK7 affects the susceptibility to Ouabain CTD PMID:16624565 oxamyl decreases activity ISO RGD:1344212 6480464 oxamyl results in decreased activity of PARK7 protein CTD PMID:36842454 oxidopamine multiple interactions ISO RGD:621808 6480464 [4-phenylbutyric acid results in increased expression of PARK7 protein] which results in decreased susceptibility to Oxidopamine more ... CTD PMID:21372141 , PMID:25129099 oxidopamine increases expression ISO RGD:1344212 6480464 Oxidopamine results in increased expression of PARK7 mRNA, Oxidopamine results in increased expression of PARK7 protein CTD PMID:18377993 oxidopamine affects localization ISO RGD:1344212 6480464 Oxidopamine affects the localization of PARK7 protein CTD PMID:18377993 oxidopamine multiple interactions ISO RGD:1344212 6480464 Oxidopamine promotes the reaction [Quinones binds to PARK7 protein] CTD PMID:20851755 oxidopamine decreases response to substance ISO RGD:1344212 6480464 PARK7 protein results in decreased susceptibility to Oxidopamine CTD PMID:18377993 oxidopamine increases expression ISO RGD:621808 6480464 Oxidopamine results in increased expression of PARK7 mRNA CTD PMID:25129099 p-menthan-3-ol decreases expression ISO RGD:1344212 6480464 Menthol results in decreased expression of PARK7 protein CTD PMID:26760959 paracetamol affects expression EXP 6480464 Acetaminophen affects the expression of PARK7 mRNA CTD PMID:17562736 paracetamol increases secretion EXP 6480464 Acetaminophen results in increased secretion of PARK7 protein CTD PMID:24038040 paracetamol increases expression ISO RGD:1344212 6480464 Acetaminophen results in increased expression of PARK7 mRNA CTD PMID:25704631 paraquat increases expression ISO RGD:1344212 6480464 Paraquat results in increased expression of PARK7 protein, Paraquat results in increased expression of PARK7 protein alternative form CTD PMID:11697128 more ... paraquat decreases expression EXP 6480464 Paraquat results in decreased expression of PARK7 mRNA CTD PMID:36108500 paraquat decreases activity ISO RGD:1344212 6480464 Paraquat results in decreased activity of PARK7 protein CTD PMID:36842454 paraquat increases response to substance EXP 6480464 PARK7 protein results in increased susceptibility to Paraquat CTD PMID:21300143 paraquat multiple interactions ISO RGD:1344212 6480464 3-(4-(morpholin-4-yl)-7H-pyrrolo(2 more ... CTD PMID:20851755 more ... paraquat multiple interactions EXP 6480464 PARK7 gene mutant form affects the reaction [Paraquat affects the expression of NFE2L2 protein] more ... CTD PMID:17823202 , PMID:21300143 perfluorododecanoic acid decreases expression ISO RGD:621808 6480464 perfluorododecanoic acid results in decreased expression of PARK7 protein CTD PMID:19854247 perfluorooctane-1-sulfonic acid multiple interactions EXP 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of PARK7 mRNA, [perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of PARK7 mRNA CTD PMID:36331819 permethrin multiple interactions ISO RGD:621808 6480464 [Pyridostigmine Bromide co-treated with DEET co-treated with Permethrin] results in increased expression of PARK7 mRNA CTD PMID:28659758 phlorizin increases expression EXP 6480464 Phlorhizin results in increased expression of PARK7 mRNA CTD PMID:22538082 pirimiphos-methyl decreases activity ISO RGD:1344212 6480464 pirimiphos methyl results in decreased activity of PARK7 protein CTD PMID:36842454 potassium chromate increases expression EXP 6480464 potassium chromate(VI) results in increased expression of PARK7 protein CTD PMID:22144121 propineb decreases activity ISO RGD:1344212 6480464 propineb results in decreased activity of PARK7 protein CTD PMID:36842454 prostaglandin E2 multiple interactions EXP 6480464 PARK7 gene mutant form inhibits the reaction [Lipopolysaccharides results in increased secretion of Dinoprostone], SB 203580 promotes the reaction [PARK7 gene mutant form inhibits the reaction [Lipopolysaccharides results in increased secretion of Dinoprostone]] CTD PMID:26691871 pyridaben decreases response to substance EXP 6480464 PARK7 protein results in decreased susceptibility to pyridaben CTD PMID:21219333 Pyridostigmine bromide multiple interactions ISO RGD:621808 6480464 [Pyridostigmine Bromide co-treated with DEET co-treated with Permethrin] results in increased expression of PARK7 mRNA CTD PMID:28659758 pyrimidifen increases expression ISO RGD:1344212 6480464 pyrimidifen results in increased expression of PARK7 mRNA CTD PMID:33512557 quercetin multiple interactions ISO RGD:621808 6480464 Quercetin inhibits the reaction [aluminum lactate results in decreased expression of PARK7 protein] CTD PMID:26493151 quercetin 3-O-beta-D-glucofuranoside multiple interactions ISO RGD:621808 6480464 isoquercitrin inhibits the reaction [Oxidopamine results in increased expression of PARK7 mRNA] CTD PMID:25129099 quercetin 3-O-beta-D-glucopyranoside multiple interactions ISO RGD:621808 6480464 isoquercitrin inhibits the reaction [Oxidopamine results in increased expression of PARK7 mRNA] CTD PMID:25129099 raloxifene increases expression EXP 6480464 Raloxifene Hydrochloride results in increased expression of PARK7 mRNA CTD PMID:33269387 resmethrin decreases activity ISO RGD:1344212 6480464 resmethrin results in decreased activity of PARK7 protein CTD PMID:36842454 rotenone multiple interactions ISO RGD:1344212 6480464 4-phenylbutyric acid inhibits the reaction [Rotenone results in increased expression of PARK7 protein] more ... CTD PMID:16439141 more ... rotenone decreases expression ISO RGD:1344212 6480464 Rotenone results in decreased expression of PARK7 protein CTD PMID:28245986 rotenone multiple interactions ISO RGD:621808 6480464 Bibenzyls inhibits the reaction [Rotenone results in decreased expression of PARK7 protein] more ... CTD PMID:28245986 rotenone decreases expression ISO RGD:621808 6480464 Rotenone results in decreased expression of PARK7 mRNA, Rotenone results in decreased expression of PARK7 protein CTD PMID:28245986 , PMID:32392329 rotenone increases response to substance EXP 6480464 PARK7 mutant form results in increased susceptibility to Rotenone CTD PMID:21219333 rotenone decreases response to substance ISO RGD:621808 6480464 PARK7 protein results in decreased susceptibility to Rotenone CTD PMID:22898350 rotenone affects response to substance ISO RGD:1344212 6480464 PARK7 protein affects the susceptibility to Rotenone CTD PMID:20940149 , PMID:26739068 rotenone increases expression ISO RGD:1344212 6480464 Rotenone results in increased expression of PARK7 mRNA, Rotenone results in increased expression of PARK7 protein CTD PMID:17459145 more ... rotenone decreases response to substance ISO RGD:1344212 6480464 PARK7 protein results in decreased susceptibility to Rotenone CTD PMID:18331584 more ... rotenone increases oxidation ISO RGD:621808 6480464 Rotenone results in increased oxidation of PARK7 protein CTD PMID:16439141 rotenone increases expression EXP 6480464 Rotenone results in increased expression of PARK7 mRNA, Rotenone results in increased expression of PARK7 protein CTD PMID:17459145 , PMID:26806867 rotenone affects localization ISO RGD:621808 6480464 Rotenone affects the localization of PARK7 protein CTD PMID:16439141 rotenone affects localization EXP 6480464 Rotenone affects the localization of PARK7 protein CTD PMID:19063952 rotenone decreases response to substance EXP 6480464 PARK7 protein results in decreased susceptibility to Rotenone CTD PMID:18930142 rotenone affects response to substance EXP 6480464 PARK7 affects the susceptibility to Rotenone CTD PMID:16624565 rotenone multiple interactions EXP 6480464 4-phenylbutyric acid inhibits the reaction [Rotenone results in increased expression of PARK7 protein] CTD PMID:17459145 rotenone affects localization ISO RGD:1344212 6480464 Rotenone affects the localization of PARK7 protein CTD PMID:16439141 more ... rutin multiple interactions ISO RGD:621808 6480464 Rutin inhibits the reaction [Oxidopamine results in increased expression of PARK7 mRNA] CTD PMID:25129099 sarin decreases expression ISO RGD:1344212 6480464 Sarin results in decreased expression of PARK7 mRNA CTD PMID:19522546 sarin decreases expression ISO RGD:621808 6480464 Sarin results in decreased expression of PARK7 protein CTD PMID:28973502 SB 203580 multiple interactions EXP 6480464 SB 203580 promotes the reaction [PARK7 gene mutant form inhibits the reaction [Lipopolysaccharides results in increased secretion of Dinoprostone]], SB 203580 promotes the reaction [PARK7 gene mutant form inhibits the reaction [Lipopolysaccharides results in increased secretion of TNF protein]] CTD PMID:26691871 silver atom increases expression EXP 6480464 Silver results in increased expression of PARK7 mRNA CTD PMID:19429238 silver(0) increases expression EXP 6480464 Silver results in increased expression of PARK7 mRNA CTD PMID:19429238 sodium arsenite increases expression ISO RGD:1344212 6480464 sodium arsenite results in increased expression of PARK7 mRNA CTD PMID:34032870 superoxide multiple interactions EXP 6480464 PARK7 protein affects the reaction [Paraquat results in increased abundance of Superoxides] CTD PMID:21300143 T-2 toxin affects expression ISO RGD:621808 6480464 T-2 Toxin affects the expression of PARK7 protein CTD PMID:26141394 tetrachloromethane decreases expression ISO RGD:621808 6480464 Carbon Tetrachloride results in decreased expression of PARK7 mRNA CTD PMID:31150632 thapsigargin increases expression ISO RGD:621808 6480464 Thapsigargin results in increased expression of PARK7 protein CTD PMID:35544339 thioacetamide decreases expression ISO RGD:621808 6480464 Thioacetamide results in decreased expression of PARK7 mRNA CTD PMID:34492290 thiram decreases activity ISO RGD:1344212 6480464 Thiram results in decreased activity of PARK7 protein CTD PMID:36842454 toluene affects expression ISO RGD:621808 6480464 Toluene affects the expression of PARK7 mRNA CTD PMID:21827849 trans-piceid multiple interactions ISO RGD:1344212 6480464 [PRKN protein affects the susceptibility to polydatin] which results in increased expression of PARK7 protein, polydatin inhibits the reaction [Rotenone results in increased expression of PARK7 protein] CTD PMID:31926197 Tri-allate decreases activity ISO RGD:1344212 6480464 Triallate results in decreased activity of PARK7 protein CTD PMID:36842454 Tributyltin oxide decreases expression EXP 6480464 bis(tri-n-butyltin)oxide results in decreased expression of PARK7 mRNA CTD PMID:22434021 tungsten increases expression EXP 6480464 Tungsten results in increased expression of PARK7 mRNA CTD PMID:30912803 valproic acid multiple interactions ISO RGD:1344212 6480464 [Hydralazine co-treated with Valproic Acid] results in increased expression of PARK7 mRNA CTD PMID:17183730 valproic acid affects expression ISO RGD:1344212 6480464 Valproic Acid affects the expression of PARK7 mRNA CTD PMID:25979313 valproic acid affects expression EXP 6480464 Valproic Acid affects the expression of PARK7 mRNA CTD PMID:17292431 vinclozolin decreases expression ISO RGD:621808 6480464 vinclozolin results in decreased expression of PARK7 mRNA CTD PMID:23034163 vorinostat decreases expression ISO RGD:1344212 6480464 vorinostat results in decreased expression of PARK7 protein CTD PMID:20543569 zineb decreases activity ISO RGD:1344212 6480464 Zineb results in decreased activity of PARK7 protein CTD PMID:36842454 ziram decreases activity ISO RGD:1344212 6480464 Ziram results in decreased activity of PARK7 protein CTD PMID:36842454
